Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
57.69 BRL | -0.67% |
|
-3.07% | -7.90% |
04/06 | Zoetis Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:40 AM | |
29/05 | Zoetis Inc. Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 09:10 AM |
Business description: Zoetis Inc.
- companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%);
- livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%);
- other (0.9%).
Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%).
At the end of 2024, the group has 22 production sites worldwide.
The United States accounts for 54.8% of net sales.
Number of employees: 13,800
Sales by Activity: Zoetis Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
United States (U.S.) | 355.7Cr | 404.2Cr | 431.3Cr | 455.5Cr | 507.4Cr |
International | 303.5Cr | 365.2Cr | 368.1Cr | 391.1Cr | 410.2Cr |
Unallocated Contract Manufacturing & Human Health | 8.3Cr | 8.2Cr | 8.6Cr | 7.8Cr | 8Cr |
Geographical breakdown of sales: Zoetis Inc.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
United States (U.S.) | 355.7Cr | 404.2Cr | 431.3Cr | 455.5Cr | 507.4Cr |
Other Emerging Markets | 66Cr | 78Cr | 76Cr | 78Cr | 86Cr |
Other Developed Markets | 39Cr | 47Cr | 47Cr | 51Cr | 56Cr |
Brazil | 26Cr | 31Cr | 33Cr | 39Cr | 41Cr |
Australia | 21Cr | 26Cr | 29Cr | 32Cr | 32Cr |
United Kingdom | 18Cr | 23Cr | 24Cr | 28Cr | 31Cr |
Canada | 21Cr | 23Cr | 24Cr | 26Cr | 28Cr |
China | 27Cr | 36Cr | 38Cr | 32Cr | 27Cr |
Germany | 16Cr | 18Cr | 18Cr | 20Cr | 22Cr |
Mexico | 12Cr | 13Cr | 14Cr | 16Cr | 17Cr |
France | 12Cr | 13Cr | 13Cr | 14Cr | 16Cr |
Japan | 18Cr | 19Cr | 17Cr | 16Cr | 15Cr |
Spain | 11Cr | 13Cr | 12Cr | 12Cr | 13Cr |
Italy | 9Cr | 12Cr | 11Cr | 12Cr | 13Cr |
Chile | 10Cr | 14Cr | 14Cr | 14Cr | 12Cr |
Unallocated | 8.3Cr | 8.2Cr | 8.6Cr | 7.8Cr | 8Cr |
Executive Committee: Zoetis Inc.
Manager | Title | Age | Since |
---|---|---|---|
Kristin Peck
CEO | Chief Executive Officer | 53 | 01/01/2020 |
Wetteny Joseph
DFI | Director of Finance/CFO | 53 | 01/06/2021 |
Julie Fuller
COO | Chief Operating Officer | 52 | 01/08/2024 |
Chief Tech/Sci/R&D Officer | - | 21/03/2024 | |
Keith Sarbaugh
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/03/2023 |
Composition of the Board of Directors: Zoetis Inc.
Director | Title | Age | Since |
---|---|---|---|
Frank D'Amelio
CHM | Chairman | 67 | 01/07/2012 |
Gregory Norden
BRD | Director/Board Member | 67 | 01/01/2013 |
Chairman | 72 | 26/06/2013 | |
Sanjay Khosla
BRD | Director/Board Member | 72 | 01/06/2013 |
Louise Parent
BRD | Director/Board Member | 74 | 01/08/2013 |
Willie Reed
BRD | Director/Board Member | 70 | 04/03/2014 |
Paul Bisaro
BRD | Director/Board Member | 64 | 01/05/2015 |
Kristin Peck
BRD | Director/Board Member | 53 | 02/10/2019 |
Director/Board Member | 63 | 08/12/2020 | |
Director/Board Member | 56 | 25/07/2022 |
Company details: Zoetis Inc.

Group companies: Zoetis Inc.
Name | Category and Sector |
---|---|
Zoetis Treasury Center BV | |
Zoetis Belgium SA
![]() Zoetis Belgium SA BiotechnologyHealth Technology Part of Zoetis, Inc., Zoetis Belgium SA is a Belgian company that manufactures animal vaccines and prescription medicines. The company is based in Louvain-La-Neuve, Belgium. |
Biotechnology
|
Zoetis Biopharmaceutical Co. Ltd. | |
Zoetis India Ltd.
![]() Zoetis India Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2007, Zoetis India Ltd. is a subsidiary of Zoetis, Inc. that manufactures vaccines and injectable biologic medicines. The company is based in Mumbai, India. |
Pharmaceuticals: Major
|
Zoetis Singapore Pte Ltd. |
Veterinary Drugs
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.32% | +6.07% | -20.33% | -34.20% | 708.71Cr | ||
-0.10% | +0.42% | -2.82% | -3.21% | 360.16Cr | ||
-0.78% | -4.23% | -10.20% | -6.07% | 307.27Cr | ||
-2.08% | -0.61% | +20.91% | -20.38% | 237.72Cr | ||
+1.76% | -18.81% | +45.21% | +28.52% | 135.33Cr | ||
-2.87% | -5.14% | +5.40% | -23.71% | 110.22Cr | ||
+0.43% | 0.00% | -15.11% | -41.44% | 100.08Cr | ||
-0.41% | +0.96% | -28.14% | -35.25% | 100Cr | ||
+1.23% | +2.51% | +37.74% | +34.56% | 99Cr | ||
Average | -0.36% | +0.18% | +3.63% | -11.24% | 239.78Cr | |
Weighted average by Cap. | -0.45% | +1.56% | -3.46% | -16.27% |
Sector

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZTS Stock
- Z1TS34 Stock
- Company Zoetis Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition